trending Market Intelligence /marketintelligence/en/news-insights/trending/7gQz5CMmyMuhWTuhW8Qeew2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

BM&FBOVESPA records 470M reais accounting loss on CME Group stake sale

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

BM&FBOVESPA records 470M reais accounting loss on CME Group stake sale

BM&FBOVESPASA said April 7 that it sold its entire 4% stake in , representing 13.6 millionshares of class A common stock, in order to raise funds for its proposed mergerwith Cetip SA.

The Brazilian stock exchange operator did not disclose the termsof the sale or the identity of the buyer, but the Financial Times reported that based on CME's closing price, the dealfetched approximately $1.3 billion for BM&FBOVESPA.

BM&FBOVESPA did note, however, that based on preliminaryestimates, the sale generated an accounting loss of 470 million Brazilian reais,which will impact the company's second-quarter earnings.

Reuters reported April 6, citing a source, that Cetip has acceptedthe terms of an overhauled merger bid from BM&FBOVESPA after two prior proposals. An official announcement is still pending.

Meanwhile, BM&FBOVESPA CEO Edemir Pinto resigned from CME'sboard, effective April 6, the U.S.-based company said in a regulatory filing. Inits statement, BM&FBOVESPA noted that CME does not currently plan to reduceits 4% stake in the Brazilian firm, and that the two entities will continue to worktogether given the success of their decadeslong partnership.

As of April 7, US$1 wasequivalent to 3.70 Brazilian reais.